About Vancomycin Dosing

This information supports the use of the Vancomycin Dosing Calculator. Vancomycin is an antibiotic used to treat serious infections caused by Gram-positive bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA). Achieving the correct dose is critical to ensure efficacy while minimizing the risk of adverse effects, particularly kidney injury (nephrotoxicity).

Pharmacokinetic (PK) principles are used to model how the body processes the drug. This allows for the calculation of an initial dosing schedule aimed at achieving a specific therapeutic target, which is then verified with therapeutic drug monitoring (TDM).

Understanding the Outputs

The calculator provides several key outputs to guide clinical decisions:

• Recommended Regimens: A list of practical dosing schedules (e.g., 1250 mg every 12 hours) that are predicted to meet the desired therapeutic target.
• Pharmacokinetic Parameters:
  • AUC24: The "Area Under the Curve" over 24 hours, representing total drug exposure. This is the recommended target for monitoring efficacy and safety.
  • Trough Level (Cmin): The lowest concentration of the drug in the bloodstream before the next dose is administered.
  • Peak Level (Cmax): The highest concentration of the drug after infusion.
  • Half-Life (T½): The time it takes for the drug concentration in the body to reduce by half.
  • Volume of Distribution (Vd): The theoretical volume that the drug occupies in the body.
• Loading Dose: A larger, single initial dose that may be given to reach the therapeutic concentration more quickly in critically ill patients.
• Concentration-Time Graph: A visual representation of how the vancomycin concentration is predicted to change over time with the suggested dosing schedule.

How to Use the Calculator

To calculate an initial vancomycin dosing regimen, follow these steps:

1. Enter Patient Data: Input the patient's age, sex, weight, height, and serum creatinine (SCr). Ensure the correct units are selected for each value.
2. Select CrCl Method: Choose the formula for calculating creatinine clearance (CrCl), a measure of kidney function. The Cockcroft-Gault equation is traditional, while CKD-EPI is often used in estimating GFR. Manual entry is also an option if CrCl is already known.
3. Define Dosing Target:
   • Select the monitoring strategy: AUC/MIC is preferred by current guidelines.
   • Enter the target AUC24 range (typically 400-600 mg*h/L for MRSA).
   • Input the Minimum Inhibitory Concentration (MIC) of the target organism, if known. An MIC of 1 mg/L is often assumed.
4. Calculate: Review the suggested dosing regimens and their predicted pharmacokinetic outcomes. The results are a starting point and are not a substitute for clinical judgment and subsequent therapeutic drug monitoring.

Dosing Overview

The 2020 consensus guidelines recommend a shift from trough-based monitoring to an AUC/MIC-guided approach for serious MRSA infections. The primary goal is to achieve an AUC24/MIC ratio of 400 to 600 to maximize bactericidal activity and reduce the risk of nephrotoxicity. A loading dose of 20-25 mg/kg of actual body weight is often recommended for critically ill patients to rapidly attain target concentrations. Maintenance doses are then administered at regular intervals (e.g., every 8, 12, or 24 hours) depending on the patient's renal function.

Switching or Adjusting Therapy

This calculator is intended for determining an initial dosing regimen. After administration, vancomycin levels must be measured. If the measured levels (e.g., trough or calculated AUC) are outside the target range, the dosing schedule (dose amount or interval) must be adjusted. This process, known as therapeutic drug monitoring (TDM), is essential for safe and effective long-term therapy.

Missed Dose Protocol

Vancomycin is administered in a supervised healthcare setting, so missed doses are uncommon. If a dose is missed, clinical staff should administer it as soon as possible and adjust the timing of subsequent doses to maintain the correct dosing interval. The specific action plan should be determined by a pharmacist or physician based on the patient's condition and the time elapsed since the missed dose.

Safety Alerts

• Nephrotoxicity: Vancomycin can cause kidney damage. The risk increases with higher doses, longer duration of therapy, high trough concentrations (>15-20 mg/L), and concomitant use of other nephrotoxic drugs. AUC-guided dosing is associated with a lower risk of nephrotoxicity compared to aggressive trough-guided dosing.
• Ototoxicity: Hearing loss or balance problems are a rare but serious side effect, typically associated with very high drug levels or pre-existing hearing impairment.
• Vancomycin Flushing Syndrome: A reaction caused by rapid infusion, characterized by flushing, itching, and a rash on the face, neck, and upper torso. To prevent this, vancomycin should be infused slowly, typically over at least 60 minutes for every 1000 mg.

Frequently Asked Questions

References

1. Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., ... & Glick, N. R. (2020). Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. American Journal of Health-System Pharmacy, 77(11), 835-864. View on PubMed
2. U.S. Food and Drug Administration (FDA). (n.d.). Vancomycin Hydrochloride prescribing information. Retrieved from the Drugs@FDA database.
3. National Kidney Foundation. (n.d.). GFR Calculators (CKD-EPI). Retrieved from kidney.org.
4. Centers for Disease Control and Prevention (CDC). (2019). Methicillin-resistant Staphylococcus aureus (MRSA). Retrieved from cdc.gov.